RxDoctor Payments Data

Aidin Iravani, MD

Pulmonary Disease · Elmira, NYNPI 1639405129

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,669 of the $7,739 with a category attached, or 73.2%. Intuitive Surgical accounts for 63.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $4,175 and has fallen 80.6% since, to $810 in 2025.

$7,739in general payments, 2019–2025

Across 38 payments — averaging $203.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$5K
  • Pulmonx Corporation$2K
  • Steris Corporation$673
  • Inari Medical, Inc.$192
  • Olympus America Inc.$50

What the payments were for

  • Consulting fees$4005%
  • Travel & lodging$5,66973%
  • Food & beverage$1,64821%
  • Gifts$220%

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,739 in reported general payments places this provider in the 80th percentile of 1,115 pulmonary disease providers in New York.

See all pulmonary disease providers in New York →

Medicare billing

Part B allowed, 2024
$64,492
Medicare patients
178
Services billed
541

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Elmira

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →